August 2017

New CDC Report Highlights the State of Antibiotic Use in the US

Published August 29, 2017

On July 27th, CDC published a new report entitled Antibiotic Use in the United States, 2017: Progress and Opportunities.  This report provides a summary of the current state of antibiotic use in various healthcare settings (hospitals, nursing homes, and outpatient clinics) in the United States.  It highlights efforts and resources that support healthcare providers and… Read More

Think Fungus: Fungal Disease Awareness Week

Published August 15, 2017

With a recent surge in the number of Candida auris infections, the CDC has designated 8/14/17-8/18/17 Fungal Infection Awareness Week.  CDC and partners organized this effort to raise awareness of recognizing serious fungal infection early in a patient’s disease process so that timely and life-saving treatment can be provided.  Go to CDC’s Think Fungus: Fungal Disease Awareness… Read More

Cephalexin With or Without TMP-SMX Showed Similar Efficacy for Uncomplicated Cellulitis

Published August 1, 2017

The Infectious Diseases Society of America recommends use of antimicrobial agent active only against streptococci (e.g., cephalexin) for management of cellulitis in patients without systemic signs of infection, penetrating trauma, evidence of MRSA, and injection drug use.  Despite this recommendation, healthcare providers frequently prescribe additional antimicrobial agents with anti-MRSA activity (e.g., cephalexin plus trimethoprim-sulfamethoxazole). A… Read More

Page last reviewed: November 8, 2018